GlassScriptPhysician profile
Candace L Douglas
NPI 1497195747
$1,072.46
in general payments reported to CMS, 2019-2025
17 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.51 · 2020: $235 · 2021: $138 · 2022: $64.91 · 2023: $276 · 2024: $83.47 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $141.86 | 2019-2020 | |
| Astellas Pharma US INC | $135.87 | 2023 | Veozah |
| Evofem Biosciences, INC. | $118.13 | 2021-2022 | |
| Biogen, INC. | $111.21 | 2025 | Zurzuvae |
| Lilly USA, LLC | $110.62 | 2020 | |
| Abbott Laboratories | $95.59 | 2023 | Freestyle Libre 2 |
| Abbvie INC. | $68.52 | 2021-2023 | Botox |
| Pfizer INC. | $53.73 | 2022-2024 | |
| Sage Therapeutics, LLC | $43.27 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $40.61 | 2025 | Watchman |
| Insulet Corporation | $37.10 | 2024-2025 | Omnipod |
| Dexcom, INC. | $26.40 | 2023 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.03 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $19.39 | 2024 | Vaxneuvance, Gardasil 9, Vaqta |
| Vertex Pharmaceuticals Incorporated | $15.83 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $14.78 | 2025 | Qelbree |
| Exact Sciences Corporation | $14.52 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.